IFNG and neoplasm: The spontaneous in vivo control of IFN-γ-signaling-mutants in our current work seems initially to be at odds with other published reports showing a loss of IFN-γ signaling on tumor cells that grew out in association with acquired resistance to anti-PD-1 therapy15,23–25.